{"id":"doi:10.1038/s41580-019-0131-5","kind":"review","title":"The next generation of CRISPR–Cas technologies and applications","authors":["Adrian Pickar‐Oliver","Charles A. Gersbach"],"author_count":2,"year":2019,"published":"2019-05-30","venue":"Nature Reviews Molecular Cell Biology","cited_by":1459,"doi":"10.1038/s41580-019-0131-5","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41580-019-0131-5","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41580-019-0131-5","updated":null,"pmid":"31147612","pmcid":null,"openalex_id":"W2947777875","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}